| Miss Janelle Pillard, PA-C | |
|
203 W Front St, Annawan, IL 61234-7756 | |
| (309) 935-4100 | |
| (309) 935-4120 |
| Full Name | Miss Janelle Pillard |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 10 Years |
| Location | 203 W Front St, Annawan, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205236569 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hammond Henry Hospital | Geneseo, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hammond Henry Dist Hospital | 0143115949 | 30 |
News Archive
Established human embryonic cell lines, including those approved for federal research funding under former President George W. Bush, are different than newly derived human embryonic stem cell lines, according to a study by UCLA stem cell researchers.
A new review aimed to describe the current state of knowledge on Sialodacryoadenitis virus, along with its characteristics and potential zoonotic threat.
NPR reports that the latest flashpoint involves a $15 billion cut from the health law's prevention trust fund. Meanwhile, The Washington Post offers a fact check on stats offered by the Romney campaign about the Obama administration and women.
Aerovance Inc. has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial(TM), of inhaled dry powder Aerovant in patients with uncontrolled asthma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Janelle Pillard, PA-C 600 N College Ave, Geneseo, IL 61254-1099 Ph: (309) 935-4100 | Miss Janelle Pillard, PA-C 203 W Front St, Annawan, IL 61234-7756 Ph: (309) 935-4100 |
News Archive
Established human embryonic cell lines, including those approved for federal research funding under former President George W. Bush, are different than newly derived human embryonic stem cell lines, according to a study by UCLA stem cell researchers.
A new review aimed to describe the current state of knowledge on Sialodacryoadenitis virus, along with its characteristics and potential zoonotic threat.
NPR reports that the latest flashpoint involves a $15 billion cut from the health law's prevention trust fund. Meanwhile, The Washington Post offers a fact check on stats offered by the Romney campaign about the Obama administration and women.
Aerovance Inc. has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial(TM), of inhaled dry powder Aerovant in patients with uncontrolled asthma.
› Verified 1 days ago